1. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. (4th March 2018) Authors: Kokolus, Kathleen M.; Zhang, Ying; Sivik, Jeffrey M.; Schmeck, Carla; Zhu, Junjia; Repasky, Elizabeth A.; Drabick, Joseph J.; Schell, Todd. D. Journal: Oncoimmunology Issue: Volume 7:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗